Literature DB >> 11852049

Point mutations confer loss of ATP-induced human P2X(7) receptor function.

R A Worthington1, M L Smart, B J Gu, D A Williams, S Petrou, J S Wiley, J A Barden.   

Abstract

Residues considered essential for ATP binding to the human P2X(7) receptor (hP2X(7)R) were investigated. HEK293 cells or Xenopus oocytes were transfected with wild-type or site-directed mutants of hP2X(7)R constructs and channel/pore activity measured in the presence of ATP or 2',3'-O-(4-benzoylbenzoyl)-ATP (BzATP). Barium uptake and ethidium influx into HEK293 cells were abolished in cells expressing K193A and K311A mutants, and were partially reduced in cells expressing mutant P210A. K193A and K311A mutations also completely abolished responses to ATP and BzATP in Xenopus oocytes as measured by electrophysiology. These results indicate that K193 and K311 are essential residues in ATP binding in the hP2X(7)R.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852049     DOI: 10.1016/s0014-5793(01)03311-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Residues 155 and 348 contribute to the determination of P2X7 receptor function via distinct mechanisms revealed by single-nucleotide polymorphisms.

Authors:  Helen J Bradley; Jocelyn M Baldwin; G Ranjan Goli; Brian Johnson; Jie Zou; Asipu Sivaprasadarao; Stephen A Baldwin; Lin-Hua Jiang
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

2.  Protein kinase C regulation of P2X3 receptors is unlikely to involve direct receptor phosphorylation.

Authors:  David A Brown; David I Yule
Journal:  Biochim Biophys Acta       Date:  2006-09-19

3.  The hyposensitive N187D P2X7 mutant promotes malignant progression in nude mice.

Authors:  Jing-Hui Chong; Guo-Guang Zheng; Yuan-Yuan Ma; Hai-Yan Zhang; Kun Nie; Yong-Min Lin; Ke-Fu Wu
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

Review 4.  Molecular properties of P2X receptors.

Authors:  Jonathan A Roberts; Catherine Vial; Helen R Digby; Kelvin C Agboh; Hairuo Wen; Amelia Atterbury-Thomas; Richard J Evans
Journal:  Pflugers Arch       Date:  2006-04-11       Impact factor: 3.657

5.  Identification and characterization of a novel variant of the human P2X(7) receptor resulting in gain of function.

Authors:  Chengqun Sun; Jessica Chu; Sarita Singh; Russell D Salter
Journal:  Purinergic Signal       Date:  2009-10-17       Impact factor: 3.765

6.  Inter-subunit disulfide cross-linking in homomeric and heteromeric P2X receptors.

Authors:  Benjamin Marquez-Klaka; Jürgen Rettinger; Annette Nicke
Journal:  Eur Biophys J       Date:  2008-04-22       Impact factor: 1.733

7.  P2X7 receptor activates extracellular signal-regulated kinases ERK1 and ERK2 independently of Ca2+ influx.

Authors:  Jan Amstrup; Ivana Novak
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

8.  Cysteine substitution mutants give structural insight and identify ATP binding and activation sites at P2X receptors.

Authors:  Jonathan A Roberts; Richard J Evans
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

9.  Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor.

Authors:  Anne N Shemon; Ronald Sluyter; Arthur D Conigrave; James S Wiley
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

10.  Insights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide Polymorphisms.

Authors:  Lin-Hua Jiang; Jocelyn M Baldwin; Sebastien Roger; Stephen A Baldwin
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.